258 related articles for article (PubMed ID: 28691157)
21. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
[TBL] [Abstract][Full Text] [Related]
22. Safety and retention rate of rufinamide in 300 patients: a single pediatric epilepsy center experience.
Thome-Souza S; Kadish NE; Ramgopal S; Sánchez Fernández I; Bergin AM; Bolton J; Harini C; Libenson M; Olson H; Peters J; Poduri A; Rotenberg A; Takeoka M; Kothare SV; Kapur K; Bourgeois BF; Loddenkemper T
Epilepsia; 2014 Aug; 55(8):1235-44. PubMed ID: 25070475
[TBL] [Abstract][Full Text] [Related]
23. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.
Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC
Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562
[TBL] [Abstract][Full Text] [Related]
24. [Clinical analysis of the effectiveness and safety of vigabatrin].
Jedrzejczak J; Owczarek K
Neurol Neurochir Pol; 2000; 34 Suppl 1():177-85. PubMed ID: 10768157
[TBL] [Abstract][Full Text] [Related]
25. Vigabatrin in uncontrolled seizures: Belgian clinical experience. The Belgian Vigabatrin Evaluation Group.
Lhoir A
Clin Neurol Neurosurg; 1994 Feb; 96(1):42-6. PubMed ID: 8187381
[TBL] [Abstract][Full Text] [Related]
26. Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs.
Overwater IE; Bindels-de Heus K; Rietman AB; Ten Hoopen LW; Vergouwe Y; Moll HA; de Wit MC
Epilepsia; 2015 Aug; 56(8):1239-45. PubMed ID: 26046563
[TBL] [Abstract][Full Text] [Related]
27. Treatment with High-Dose Prednisolone in Vigabatrin-Refractory Infantile Spasms.
Al-Shehhi W; Chau V; Boyd J; Snead C; Sharma R; Donner E; Go C; Jain P
Can J Neurol Sci; 2022 Jul; 49(4):532-539. PubMed ID: 34212837
[TBL] [Abstract][Full Text] [Related]
28. Vigabatrin treatment in children.
Fois A; Buoni S; Di Bartolo RM; Di Marco V; Mostardini R
Childs Nerv Syst; 1994 May; 10(4):244-8. PubMed ID: 7923235
[TBL] [Abstract][Full Text] [Related]
29. Epileptic spasms in tuberous sclerosis complex.
Hsieh DT; Jennesson MM; Thiele EA
Epilepsy Res; 2013 Sep; 106(1-2):200-10. PubMed ID: 23796861
[TBL] [Abstract][Full Text] [Related]
30. The impact of hypsarrhythmia on infantile spasms treatment response: Observational cohort study from the National Infantile Spasms Consortium.
Demarest ST; Shellhaas RA; Gaillard WD; Keator C; Nickels KC; Hussain SA; Loddenkemper T; Patel AD; Saneto RP; Wirrell E; Sánchez Fernández I; Chu CJ; Grinspan Z; Wusthoff CJ; Joshi S; Mohamed IS; Stafstrom CE; Stack CV; Yozawitz E; Bluvstein JS; Singh RK; Knupp KG;
Epilepsia; 2017 Dec; 58(12):2098-2103. PubMed ID: 29105055
[TBL] [Abstract][Full Text] [Related]
31. [Vigabatrin in the treatment of intractable focal epilepsy in children and adolescents. Two-year study].
Kozik A; Ujma-Czapska B; Grotowska M
Neurol Neurochir Pol; 2000; 34 Suppl 1():187-93. PubMed ID: 10768158
[TBL] [Abstract][Full Text] [Related]
32. Early epileptiform EEG activity in infants with tuberous sclerosis complex predicts epilepsy and neurodevelopmental outcomes.
De Ridder J; Verhelle B; Vervisch J; Lemmens K; Kotulska K; Moavero R; Curatolo P; Weschke B; Riney K; Feucht M; Krsek P; Nabbout R; Jansen AC; Wojdan K; Domanska-Pakieła D; Kaczorowska-Frontczak M; Hertzberg C; Ferrier CH; Samueli S; Benova B; Aronica E; Kwiatkowski DJ; Jansen FE; Jóźwiak S; Lagae L;
Epilepsia; 2021 May; 62(5):1208-1219. PubMed ID: 33778971
[TBL] [Abstract][Full Text] [Related]
33. Vigabatrin in chronic epilepsy: a 7-year follow-up study of responder patients.
Cocito L; Maffini M; Loeb C
Seizure; 1993 Dec; 2(4):301-7. PubMed ID: 8162400
[TBL] [Abstract][Full Text] [Related]
34. Felbamate in the treatment of refractory epileptic spasms.
Hussain SA; Asilnejad B; Heesch J; Navarro M; Ji M; Shrey DW; Rajaraman RR; Sankar R
Epilepsy Res; 2020 Mar; 161():106284. PubMed ID: 32058261
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and Tolerability of Rufinamide in Epileptic Children Younger Than 4 Years.
Tanritanir A; Wang X; Loddenkemper T
J Child Neurol; 2021 Mar; 36(4):281-287. PubMed ID: 33231110
[TBL] [Abstract][Full Text] [Related]
36. Short-Term Outcome of Intravenous Methylprednisolone Pulse Therapy in Patients With Infantile Spasms.
Yeh HR; Kim MJ; Ko TS; Yum MS; You SJ
Pediatr Neurol; 2017 Jun; 71():50-55. PubMed ID: 28483397
[TBL] [Abstract][Full Text] [Related]
37. Vigabatrin for infantile spasms.
Mitchell WG; Shah NS
Pediatr Neurol; 2002 Sep; 27(3):161-4. PubMed ID: 12393124
[TBL] [Abstract][Full Text] [Related]
38. Vigabatrin: a novel therapy for seizure disorders.
Gidal BE; Privitera MD; Sheth RD; Gilman JT
Ann Pharmacother; 1999 Dec; 33(12):1277-86. PubMed ID: 10630829
[TBL] [Abstract][Full Text] [Related]
39. Seizure characteristics and the use of anti-epileptic drugs in children and young people with brain tumours and epileptic seizures: Analysis of regional paediatric cancer service population.
Pilotto C; Liu JF; Walker DA; Whitehouse WP
Seizure; 2018 May; 58():17-21. PubMed ID: 29609145
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy.
Remy C; Beaumont D
Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):125S-129S. PubMed ID: 2757903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
